AI assistant
Sending…
Sopharma AD — Earnings Release 2019
Oct 7, 2019
2543_rns_2019-10-07_496014b6-3a0e-4b01-974b-369116d0bed5.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report № 60/ 2019 Dated October 7, 2019
NOTIFICATION
Sopharma AD (the "Company") notifies that for September 2019 the Company recorded an increase in sales of 31% compared to the same month of 2018, incl. 5% decrease in sales for the domestic market and 66% increase in export sales.
In the first nine months of 2019 the revenues from sales of production increased by 2% compared to the same period of 2018, incl. 9% decrease in domestic sales and 10% increase in export sales.
Signatures of individuals authorized to represent the Company:
Ognian Donev
More from Sopharma AD
Transaction in Own Shares
2026
May 28
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Transaction in Own Shares
2026
May 19
Transaction in Own Shares
2026
May 18
Transaction in Own Shares
2026
May 15